Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Comment by HighBuyon Jul 08, 2014 11:57pm

112 Views

Post# 22727351

RE:RE:Price-Volume

So if I understand you correctly a merger or an agreement for production with another biggger company with royalties would be what the company wants and needs.

As per the volume, I believe that is very important in determining when to buy. You dont want to invest in the company and it be neutral for 4 months. Using volume anaylysis you can get it right most to all the time.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity